TipRanks
Elixxer (ELIXF)
OTHER OTC:ELIXF

Elixxer (ELIXF) Price & Analysis

9 Followers

ELIXF Stock Chart & Stats

$0.03
$0.00(0.00%)
At close: 4:00 PM EST
$0.03
$0.00(0.00%)

Elixxer News

ELIXF FAQ

What was Elixxer’s price range in the past 12 months?
Elixxer lowest stock price was $0.01 and its highest was $0.10 in the past 12 months.
    What is Elixxer’s market cap?
    Elixxer’s market cap is $2.72M.
      When is Elixxer’s upcoming earnings report date?
      Elixxer’s upcoming earnings report date is Nov 19, 2026 which is in 23 days.
        How were Elixxer’s earnings last quarter?
        Elixxer released its earnings results on Aug 31, 2026. The company reported -$0.006 earnings per share for the quarter.
          Is Elixxer overvalued?
          According to Wall Street analysts Elixxer’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Elixxer pay dividends?
            Elixxer does not currently pay dividends.
            What is Elixxer’s EPS estimate?
            Elixxer’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Elixxer have?
            Elixxer has 95,263,040 shares outstanding.
              What happened to Elixxer’s price movement after its last earnings report?
              Elixxer reported an EPS of -$0.006 in its last earnings report. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Elixxer?
                Currently, no hedge funds are holding shares in ELIXF
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  Company Description

                  Elixxer

                  Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cannabis-related businesses, which are fully licensed for cultivation, production, and/or sale of medical and specialty cannabis and cannabis-derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. was incorporated in 2004 and is based in Montreal, Canada.

                  Elixxer (ELIXF) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Global Hemp
                  ―
                  ―
                  ―
                  ―
                  ―
                  CENTR Brands
                  ―
                  ―
                  ―
                  ―
                  ―
                  Xebra Brands Ltd.
                  ―
                  ―

                  Ownership Overview

                  84.28%15.72%
                  84.28% Insiders
                  ― Other Institutional Investors
                  15.72% Public Companies and
                  Individual Investors
                  Popular Stocks